4 ms·
> The records must be reviewed to redact “confidential business and trade secret information of Pfizer or BioNTech and personal privacy information of patients
by walterbell 5y ago
> The records must be reviewed to redact “confidential business and trade secret information of Pfizer or BioNTech and personal privacy information of patients who participated in clinical trials”
Wouldn't this separation be designed into the process for data management during the clinical trial?
Almost all content is managed by computer systems that are designed to protect PII and intellectual property, with managed restriction or redaction for external distribution. If it did not take decades for computer-structured clinical trial data to move across the corporation->government boundary, why would it take decades to move from government->citizens?
If necessary, the reports can be re-exported from the corporate systems used for clinical trial data management, with additional computer-enforced redaction of sensitive data. There is also AI-assisted software used in legal discovery, which can quickly parse a large document corpus, to flag material for human review.
- smnrchrds 5y ago> it did not take decades for computer-structured clinical trial data to move across the corporation->government boundary Do companies redact patient data before submitting it to the FDA? Are they even allowed to? That sounds like the sort of information that the FDA should have access to.
- throwawayboise 5y agoWhy would the FDA need the PII from the patient data?
- smnrchrds 5y agoPII is not just name and SSN. Using all the demographic information recorded for each participant and open-source intelligence, you should be able to uniquely identify them.
- Fomite 5y agoAny dates that have more than the year in them are PHI.
- Brybry 5y ago> FDA may inspect study records, for example, to assess investigator compliance with the study protocol and the validity of the data reported by the sponsor https://www.fda.gov/regulatory-information/search-fda-guidance-documents/informed-consent#confidentiality https://www.fda.gov/regulatory-information/search-fda-guidan... https://www.fda.gov/media/75185/download https://www.fda.gov/media/75185/download
- BurningFrog 5y agoTo verify that they're not made up?
- throwawayboise 5y agoThese companies were also granted liability waivers for these vaccines (and are making record profits from them). They should not get to preserve any "trade secrets."
- giantg2 5y agoNot to mention they agreed to let other companies manufacture/use their formula (or so they say).
- barry-cotter 5y ago> (and are making record profits from them) Man, if that were true it would be great. It would show that we could reward providing society with enormous benefts with enormous awards. If only that were true.
- reducesuffering 5y agoModerna and BioNTech both made around $7 billion profit each, not revenue, just last year. Because of this, their share price is also up 11x since IPO 3 years ago, and 16x since IPO 2 years ago, respectively. https://finance.yahoo.com/quote/MRNA/financials?p=MRNA https://finance.yahoo.com/quote/MRNA/financials?p=MRNA https://finance.yahoo.com/quote/BNTX/financials?p=BNTX https://finance.yahoo.com/quote/BNTX/financials?p=BNTX
- Kranar 5y agoDamn, imagine making a world changing product used by close to half of the world's population to overcome a global crisis... and making less profit than a company that sells highly marked up leather bags. Kind of a depressing thought the extent to which we prioritize things.
- reducesuffering 5y agoDo not get me started on what disturbing problems exist for LVMH to be a $360 billion company in this world...
- DannyBee 5y agoThe FDA is required by the CFR to redact certain things from the publicly available file. The privately available file (IE what they get) is not redacted. You are correct that there are complex data management systems managing the trial, but i don't think they can quite meet all the CFR requirements in practice. At least, they couldn't when i used to know a lot more about this. Neither side is right - the plaintiffs are playing language games in a lot of places to make it seem like this is easy. Even with the management systems, it's not. Th FDA is playing games in saying thy need to review 330,000 pages (like, tons of them are just trial data and chart results. They are standardized page formats, etc. There will be no additional text or names.)
- Jansen312 5y agoFDA fuck up. There are definitely incriminating evidence in there. FDA is not FBI or CIA. They should have zero ability to redact. The only things they will actively redact will be to cover their ass. 55 years long enough for those that incriminate to die off.
- Marc6919 5y agoThey should have redacted the info when they had advisory Committee's review it to recommend boosters and vaccines for kids. Usually when govt has personal identification, they use numeric identifiers in documents as HIPPA is very strict with personal identification. Proprietary data should be concentrated in specific documents and easily redacted. There is no excuse for what they are doing. I have worked with MEDI-CALand Sicial Security information on several occasions as an auditor and a fraud investigator. They have the resources and much of the proprietary and personal information is already coded in a manner that an outsider would not be able to decipher. 500 pages a month is ludicrous.
- dragonwriter 5y ago> Wouldn't this separation be designed into the process for data management during the clinical trial? No. > Almost all content is managed by computer systems that are designed to protect PII and intellectual property Having worked in public sector entities dealing with masses of private data that deals with public records requests against that data for decades, no, its almost certainly mostly not, > If it did not take decades for computer-structured clinical trial data to move across the corporation->government boundary, why would it take decades to move from government->citizens? Because the first transition basically requires the confidential data, and even where it doesn't strictly require it, it is low legal risk in the event of error because the government is bound not to release it. > If necessary, the reports can be re-exported from the corporate systems No, even if that was useful, they legally can't, because only the records actually held by the government are subject to FOIA. The material held in corporate systems from which reports were made to the federal government is not subject to FOIA.
- dolni 5y ago> The material held in corporate systems from which reports were made to the federal government is not subject to FOIA. This sounds like an entire problem of its own. We're talking a medical treatment the government is doing its damnedest to mandate. There needs to be an exceptional level of transparency here.
- Marc6919 5y agoYeah, with 18,000 employees and a $6 Billion annual budget, the FDA clearly has sufficient resources to process the data. All personal information would be already be coded or assigned a numeric ID that would make it impossible to identify specific participants without the master key. To represent that this project would require additional resources via congressional action is complete nonsense. Redactions should have already been performed as most of this information has been reviewed during the FDA approval processes. I expect the judge will find that the March 2022 date requested by FOIA will be seriously considered by the Judge on December 14th, as people are being fired for not complying with vaccine mandates and this would merit an urgent matter. I can't believe they tried to release only 500 pages per month in thos polarized environment we live in.